West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 593,400 | 456,400 | 295,100 | 140,000 | 585,900 |
| Depreciation Amortization | 137,300 | 101,400 | 65,700 | 31,600 | 120,600 |
| Income taxes - deferred | 37,500 | N/A | N/A | N/A | -30,800 |
| Accounts receivable | 4,000 | N/A | N/A | N/A | -35,600 |
| Accounts payable and accrued liabilities | 4,400 | N/A | N/A | N/A | -2,800 |
| Other Working Capital | -20,400 | -47,300 | -72,100 | -46,800 | -15,000 |
| Other Operating Activity | 20,300 | 26,900 | 18,600 | 13,300 | 101,700 |
| Operating Cash Flow | $776,500 | $537,400 | $307,300 | $138,100 | $724,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -362,000 | -253,300 | -157,500 | -82,100 | -284,600 |
| Other Investing Activity | -6,700 | -6,600 | -6,700 | 0 | -3,600 |
| Investing Cash Flow | $-368,700 | $-259,900 | $-164,200 | $-82,100 | $-288,200 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,400 | -1,700 | -1,100 | -600 | -44,300 |
| Common Stock Issued | 51,000 | 47,900 | 27,500 | 15,300 | 28,200 |
| Common Stock Repurchased | -451,200 | -274,100 | -246,000 | -71,600 | -222,200 |
| Dividend Paid | -57,000 | -42,200 | -28,200 | -14,100 | -54,100 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -1,200 |
| Financing Cash Flow | $-459,600 | $-270,100 | $-247,800 | $-71,000 | $-293,600 |
| Exchange Rate Effect | 11,400 | -3,100 | 6,700 | 7,000 | -10,500 |
| Beginning Cash Position | 894,300 | 894,300 | 894,300 | 894,300 | 762,600 |
| End Cash Position | 853,900 | 898,600 | 796,300 | 886,300 | 894,300 |
| Net Cash Flow | $-40,400 | $4,300 | $-98,000 | $-8,000 | $131,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | 776,500 | 537,400 | 307,300 | 138,100 | 724,000 |
| Capital Expenditure | -362,000 | -253,300 | -157,500 | -82,100 | -284,600 |
| Free Cash Flow | 414,500 | 284,100 | 149,800 | 56,000 | 439,400 |